EQ
Price
$0.47
Change
-$0.01 (-2.08%)
Updated
Apr 24 closing price
Capitalization
16.79M
13 days until earnings call
PRQR
Price
$1.54
Change
+$0.09 (+6.21%)
Updated
Apr 24 closing price
Capitalization
162.03M
13 days until earnings call
Ad is loading...

EQ vs PRQR

Header iconEQ vs PRQR Comparison
Open Charts EQ vs PRQRBanner chart's image
Equillium
Price$0.47
Change-$0.01 (-2.08%)
Volume$264.21K
Capitalization16.79M
ProQR Therapeutics
Price$1.54
Change+$0.09 (+6.21%)
Volume$1.21M
Capitalization162.03M
EQ vs PRQR Comparison Chart
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. PRQR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Buy and PRQR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (EQ: $0.47 vs. PRQR: $1.54)
Brand notoriety: EQ and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 221% vs. PRQR: 201%
Market capitalization -- EQ: $16.79M vs. PRQR: $162.03M
EQ [@Biotechnology] is valued at $16.79M. PRQR’s [@Biotechnology] market capitalization is $162.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, both EQ and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 6 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • EQ’s TA Score: 6 bullish, 4 bearish.
  • PRQR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EQ is a better buy in the short-term than PRQR.

Price Growth

EQ (@Biotechnology) experienced а -0.53% price change this week, while PRQR (@Biotechnology) price change was +35.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

EQ is expected to report earnings on Aug 06, 2025.

PRQR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($162M) has a higher market cap than EQ($16.8M). EQ YTD gains are higher at: -37.183 vs. PRQR (-41.887). EQ has higher annual earnings (EBITDA): -4.46M vs. PRQR (-24.12M). PRQR has more cash in the bank: 149M vs. EQ (25.9M). EQ has less debt than PRQR: EQ (497K) vs PRQR (17.2M). EQ has higher revenues than PRQR: EQ (45.9M) vs PRQR (18.9M).
EQPRQREQ / PRQR
Capitalization16.8M162M10%
EBITDA-4.46M-24.12M19%
Gain YTD-37.183-41.88789%
P/E RatioN/AN/A-
Revenue45.9M18.9M243%
Total Cash25.9M149M17%
Total Debt497K17.2M3%
FUNDAMENTALS RATINGS
EQ vs PRQR: Fundamental Ratings
EQ
PRQR
OUTLOOK RATING
1..100
312
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
9588
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (19) in the Biotechnology industry is in the same range as PRQR (30). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

EQ's SMR Rating (92) in the Biotechnology industry is in the same range as PRQR (94). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's Price Growth Rating (88) in the Biotechnology industry is in the same range as EQ (95). This means that PRQR’s stock grew similarly to EQ’s over the last 12 months.

PRQR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EQ (100). This means that PRQR’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EQPRQR
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUST1.240.11
+9.73%
Austin Gold Corp
OLO6.220.21
+3.49%
Olo
CSWI314.3010.09
+3.32%
CSW Industrials
SSTI15.350.01
+0.03%
SoundThinking
FE42.28-0.29
-0.68%
FirstEnergy Corp

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MTNB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
-2.08%
MTNB - EQ
38%
Loosely correlated
+1.71%
IMNM - EQ
33%
Poorly correlated
+0.24%
PRQR - EQ
26%
Poorly correlated
+6.21%
WVE - EQ
25%
Poorly correlated
N/A
MURA - EQ
24%
Poorly correlated
-4.69%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+6.21%
KRRO - PRQR
59%
Loosely correlated
-2.90%
ATNF - PRQR
57%
Loosely correlated
-0.13%
WVE - PRQR
56%
Loosely correlated
N/A
ENVB - PRQR
43%
Loosely correlated
+3.47%
RCKT - PRQR
34%
Loosely correlated
+4.06%
More